Skip to main content
MDListen

MDListen

By MDListen

These programs have been developed, and are intended for healthcare professionals.

MDListen is a podcast series brought to you by MD-Online. MDListen will keep you informed of the latest developments in medicine and clinical practice.
Available on
Apple Podcasts Logo
Google Podcasts Logo
Overcast Logo
Pocket Casts Logo
RadioPublic Logo
Spotify Logo
Currently playing episode

Elevated triglycerides: risk marker or risk factor?

MDListenJun 30, 2020

00:00
32:53
Elevated triglycerides: risk marker or risk factor?

Elevated triglycerides: risk marker or risk factor?

Featuring: Dr. Alan D. Bell and Dr. Robert Hegele

A copy of the programs slides and transcript are available for download on: https://www.md-online.com/podcasts/

Discussion topics:

1. Management challenges for high-risk cardiovascular patients in primary care.

2. Are elevated triglycerides associated with cardiovascular risk?

3. What is the impact of triglyceride lowering on cardiovascular risk?

4. What is the effect of fish oil, Omega-3 FA and IPE on triglyceride levels and cardiovascular outcomes.

This program was been developed by the Canadian Collaborative Research Network (www.ccrnmd.com)

Jun 30, 202032:53
Icosapent ethyl for CV risk reduction: who and when?

Icosapent ethyl for CV risk reduction: who and when?

Featuring: Dr. Milan Gupta and Dr. Shaun Goodman

A copy of the programs slides and transcript are available for download on: https://www.md-online.com/podcasts/

Discussion topics:

1. Do serum triglycerides predict risk?

2. Do fish oils reduce risk?

3. What are the key results from REDUCE-IT?

4. In which patients should we consider icosapent ethyl?

This program was been developed by the Canadian Collaborative Research Network (www.ccrnmd.com)

Jun 05, 202028:04
MDListen Trailer

MDListen Trailer

Coming soon: MDListen, a podcast series brought to you by MD-Online. MDListen will keep you informed of the latest developments in medicine and clinical practice. 

May 26, 202000:14